PT80663B - Process for preparing epoxysteroids - Google Patents

Process for preparing epoxysteroids

Info

Publication number
PT80663B
PT80663B PT80663A PT8066385A PT80663B PT 80663 B PT80663 B PT 80663B PT 80663 A PT80663 A PT 80663A PT 8066385 A PT8066385 A PT 8066385A PT 80663 B PT80663 B PT 80663B
Authority
PT
Portugal
Prior art keywords
epoxysteroids
preparing
preparing epoxysteroids
Prior art date
Application number
PT80663A
Other languages
English (en)
Portuguese (pt)
Other versions
PT80663A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT80663A publication Critical patent/PT80663A/pt
Publication of PT80663B publication Critical patent/PT80663B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT80663A 1984-06-21 1985-06-19 Process for preparing epoxysteroids PT80663B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (2)

Publication Number Publication Date
PT80663A PT80663A (en) 1985-07-01
PT80663B true PT80663B (en) 1987-05-08

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80663A PT80663B (en) 1984-06-21 1985-06-19 Process for preparing epoxysteroids

Country Status (16)

Country Link
US (1) US4670551A (OSRAM)
EP (1) EP0165902B1 (OSRAM)
AR (2) AR242036A1 (OSRAM)
AU (1) AU582754B2 (OSRAM)
CA (1) CA1239388A (OSRAM)
DE (1) DE3569540D1 (OSRAM)
DK (1) DK173854B1 (OSRAM)
ES (2) ES8704967A1 (OSRAM)
FI (1) FI83225C (OSRAM)
GR (1) GR851499B (OSRAM)
HU (1) HU192232B (OSRAM)
IE (1) IE58050B1 (OSRAM)
IL (1) IL75569A (OSRAM)
NO (1) NO165496C (OSRAM)
NZ (1) NZ212492A (OSRAM)
PT (1) PT80663B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0973791B1 (en) * 1995-12-11 2007-06-20 G.D. Searle LLC. Process for the preparation of an epoxy compound
DE69738225T2 (de) 1996-12-11 2008-07-17 G.D. Searle Llc, Chicago Epoxidierungsverfahren
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1148061B1 (en) * 1996-12-11 2007-10-17 G.D. Searle LLC. Epoxidation process
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
PL371128A1 (en) 2001-12-12 2005-06-13 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
DE3481707D1 (de) * 1983-08-17 1990-04-26 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Also Published As

Publication number Publication date
FI852430A0 (fi) 1985-06-19
AR245731A1 (es) 1994-02-28
PT80663A (en) 1985-07-01
DK173854B1 (da) 2001-12-27
GR851499B (OSRAM) 1985-11-25
IE851535L (en) 1985-12-21
IL75569A (en) 1989-03-31
DK280085A (da) 1985-12-22
ES544387A0 (es) 1987-04-16
CA1239388A (en) 1988-07-19
NZ212492A (en) 1989-02-24
US4670551A (en) 1987-06-02
NO165496C (no) 1991-02-20
HU192232B (en) 1987-05-28
ES557112A0 (es) 1987-08-16
NO165496B (no) 1990-11-12
IL75569A0 (en) 1985-10-31
EP0165902A3 (en) 1986-10-22
FI83225C (fi) 1991-06-10
FI83225B (fi) 1991-02-28
DE3569540D1 (en) 1989-05-24
ES8704967A1 (es) 1987-04-16
FI852430L (fi) 1985-12-22
IE58050B1 (en) 1993-06-16
AR242036A1 (es) 1993-02-26
ES8707737A1 (es) 1987-08-16
AU582754B2 (en) 1989-04-13
NO852501L (no) 1985-12-23
EP0165902B1 (de) 1989-04-19
DK280085D0 (da) 1985-06-20
HUT38367A (en) 1986-05-28
AU4397185A (en) 1986-01-02
EP0165902A2 (de) 1985-12-27

Similar Documents

Publication Publication Date Title
PT79890B (en) Process for preparing tetrahydro-methylimidazolylcarbazolones
PT81299A (en) Process for preparing alkylsulfonamidophenylalkylamines
PT81463A (en) Process for preparing novel 5-amino-4-hidroxyvalerylderivatives
PT81225A (en) Process for preparing triazoloquinazoline compounds
HUT38658A (en) Process for preparing olefin-polymers
HUT37629A (en) Process for preparing 9a-aza-9a-homoerythromycine-derivatives
HUT39177A (en) Process for preparing new isoindolyl-alkyl-piperazine-derivatives
ZA858835B (en) Process for preparing 4-aminodiphenylamines
PT80597B (en) Process for preparing di-hydropiridines
PT80663B (en) Process for preparing epoxysteroids
HUT40087A (en) Process for preparing new quinazolindione-derivatives
GB2175583B (en) Process for preparing n-acylphenylalanines
HUT38942A (en) Process for preparing substituted 7-oxo-mitosanes
EP0165595A3 (en) Process for preparing 5-deoxy-l-arabinose
IL76816A (en) Process for preparing 13-hydroxy-5-ketomilbemycin
HUT39424A (en) Process for preparing hidroxy-thia-alkenes
HUT44564A (en) Novel process for preparing piroxicam-propharmakon
PT80816B (en) Process for preparing pyridazinylimidazolidinone compounds
GB2162839B (en) Process for preparing aminobenzylamine
DE3564569D1 (en) Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide
DE3563448D1 (en) Process for preparing polyphenylenethers
ZA854926B (en) Process for preparing anmonia
HUT38395A (en) Process for preparing chanoclavine
HUT39163A (en) Process for preparing 5-cyano-1-phenyl-n-methyl-1h-pyrazole-4-carboxamide
DE3560394D1 (en) Process for preparing 1-amino-2-bromo-4-hydroxy-anthraquinone

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 970618 NOVARTIS AG CH

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031130